New treatment options for postoperative care of cataract surgery are minimizing the need for ophthalmic eye drops.
Treatment plans for pediatric patients with keratoconus may get an upgrade soon with this newly approved technology.
Research reveals latanoprost-eluting contact lenses may one day replace daily eye drops.
New antibiotics are scarce—here’s why, and what’s being done about it.
New formulations of an old drug may mean better treatments for dry eye.
New mucin-enhancing drug could support tear film stability from the ground up.
Could the latest approach to steroid therapy conquer noncompliance once and for all?
The FDA recently requested more data on this investigational dry eye drug. What’s known—and what’s next?
Adenoviral infections remain the number one cause of urgent care visits to eye care practitioners' offices.
Updates to the FDA’s pregnancy drug categorization system mean changes for your practice.
Literature suggests this immunosuppressant may be suited to treat more conditions than you might think.
Corneal neovascularization from contact lens overwear and other hypoxic events may respond to this posterior segment therapy.
Researchers continue to make strides in reducing the impact of this common condition. Here’s a look at the latest steps.
Are you fully considering Demodex
in your work-ups and treatment decisions?
Ongoing research reveals how to better manage dry eye with autologous serum eye drops.
A new report shows promising data. Which hurdles have been overcome, and which remain?
Even if you aren't prescribing these to your patients, others may be. Here's an overview.
Updated information from SCUT and a new in-office diagnostic test may help us provide better treatment options for many patients.
These popular drugs are essential to the care we provide. Why have fluoroquinolones become such workhorse drugs? Where might they be headed? Let's find out.